These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

395 related articles for article (PubMed ID: 24135932)

  • 1. N2 neutrophils, novel players in brain inflammation after stroke: modulation by the PPARγ agonist rosiglitazone.
    Cuartero MI; Ballesteros I; Moraga A; Nombela F; Vivancos J; Hamilton JA; Corbí ÁL; Lizasoain I; Moro MA
    Stroke; 2013 Dec; 44(12):3498-508. PubMed ID: 24135932
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Peroxisome proliferator-activated receptor-gamma agonists induce neuroprotection following transient focal ischemia in normotensive, normoglycemic as well as hypertensive and type-2 diabetic rodents.
    Tureyen K; Kapadia R; Bowen KK; Satriotomo I; Liang J; Feinstein DL; Vemuganti R
    J Neurochem; 2007 Apr; 101(1):41-56. PubMed ID: 17394460
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis of lipoxin A4 by 5-lipoxygenase mediates PPARgamma-dependent, neuroprotective effects of rosiglitazone in experimental stroke.
    Sobrado M; Pereira MP; Ballesteros I; Hurtado O; Fernández-López D; Pradillo JM; Caso JR; Vivancos J; Nombela F; Serena J; Lizasoain I; Moro MA
    J Neurosci; 2009 Mar; 29(12):3875-84. PubMed ID: 19321784
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuroprotection against focal ischemic brain injury by the peroxisome proliferator-activated receptor-gamma agonist rosiglitazone.
    Luo Y; Yin W; Signore AP; Zhang F; Hong Z; Wang S; Graham SH; Chen J
    J Neurochem; 2006 Apr; 97(2):435-48. PubMed ID: 16539667
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation of RXR/PPARγ underlies neuroprotection by bexarotene in ischemic stroke.
    Certo M; Endo Y; Ohta K; Sakurada S; Bagetta G; Amantea D
    Pharmacol Res; 2015 Dec; 102():298-307. PubMed ID: 26546745
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rosiglitazone Promotes White Matter Integrity and Long-Term Functional Recovery After Focal Cerebral Ischemia.
    Han L; Cai W; Mao L; Liu J; Li P; Leak RK; Xu Y; Hu X; Chen J
    Stroke; 2015 Sep; 46(9):2628-36. PubMed ID: 26243225
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dynamic changes in pro- and anti-inflammatory cytokines in microglia after PPAR-γ agonist neuroprotective treatment in the MPTPp mouse model of progressive Parkinson's disease.
    Pisanu A; Lecca D; Mulas G; Wardas J; Simbula G; Spiga S; Carta AR
    Neurobiol Dis; 2014 Nov; 71():280-91. PubMed ID: 25134730
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rosiglitazone-induced CD36 up-regulation resolves inflammation by PPARγ and 5-LO-dependent pathways.
    Ballesteros I; Cuartero MI; Pradillo JM; de la Parra J; Pérez-Ruiz A; Corbí A; Ricote M; Hamilton JA; Sobrado M; Vivancos J; Nombela F; Lizasoain I; Moro MA
    J Leukoc Biol; 2014 Apr; 95(4):587-98. PubMed ID: 24338629
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of TLR4 (Toll-Like Receptor 4) in N1/N2 Neutrophil Programming After Stroke.
    García-Culebras A; Durán-Laforet V; Peña-Martínez C; Moraga A; Ballesteros I; Cuartero MI; de la Parra J; Palma-Tortosa S; Hidalgo A; Corbí AL; Moro MA; Lizasoain I
    Stroke; 2019 Oct; 50(10):2922-2932. PubMed ID: 31451099
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Delayed post ischemic treatment with Rosiglitazone attenuates infarct volume, neurological deficits and neutrophilia after embolic stroke in rat.
    Allahtavakoli M; Moloudi R; Arababadi MK; Shamsizadeh A; Javanmardi K
    Brain Res; 2009 May; 1271():121-7. PubMed ID: 19332033
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The intracerebral application of the PPARgamma-ligand pioglitazone confers neuroprotection against focal ischaemia in the rat brain.
    Zhao Y; Patzer A; Gohlke P; Herdegen T; Culman J
    Eur J Neurosci; 2005 Jul; 22(1):278-82. PubMed ID: 16029218
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Resolution of Inflammation by Resolvin D1 Is Essential for Peroxisome Proliferator-activated Receptor-γ-mediated Analgesia during Postincisional Pain Development in Type 2 Diabetes.
    Saito T; Hasegawa-Moriyama M; Kurimoto T; Yamada T; Inada E; Kanmura Y
    Anesthesiology; 2015 Dec; 123(6):1420-34. PubMed ID: 26492476
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PPARgamma agonist rosiglitazone is neuroprotective after traumatic brain injury via anti-inflammatory and anti-oxidative mechanisms.
    Yi JH; Park SW; Brooks N; Lang BT; Vemuganti R
    Brain Res; 2008 Dec; 1244():164-72. PubMed ID: 18948087
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rosiglitazone, a peroxisome proliferator-activated receptor-γ agonist, attenuates airway inflammation by inhibiting the proliferation of effector T cells in a murine model of neutrophilic asthma.
    Zhao Y; Huang Y; He J; Li C; Deng W; Ran X; Wang D
    Immunol Lett; 2014; 157(1-2):9-15. PubMed ID: 24269293
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuroprotective effects of pioglitazone in a rat model of permanent focal cerebral ischemia are associated with peroxisome proliferator-activated receptor gamma-mediated suppression of nuclear factor-κB signaling pathway.
    Zhang HL; Xu M; Wei C; Qin AP; Liu CF; Hong LZ; Zhao XY; Liu J; Qin ZH
    Neuroscience; 2011 Mar; 176():381-95. PubMed ID: 21185913
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activation of cerebral peroxisome proliferator-activated receptors γ (PPARγ) reduces neuronal damage in the substantia nigra after transient focal cerebral ischaemia in the rat.
    Zuhayra M; Zhao Y; von Forstner C; Henze E; Gohlke P; Culman J; Lützen U
    Neuropathol Appl Neurobiol; 2011 Dec; 37(7):738-52. PubMed ID: 21366664
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peroxisome proliferator-activated receptor-gamma: potential molecular therapeutic target for HIV-1-associated brain inflammation.
    Omeragic A; Hoque MT; Choi UY; Bendayan R
    J Neuroinflammation; 2017 Sep; 14(1):183. PubMed ID: 28886715
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PPARγ agonist rosiglitazone is neuroprotective after traumatic spinal cord injury via anti-inflammatory in adult rats.
    Zhang Q; Hu W; Meng B; Tang T
    Neurol Res; 2010 Oct; 32(8):852-9. PubMed ID: 20350367
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peroxisome proliferator-activated receptorsgamma (PPARgamma) differently modulate the interleukin-6 expression in the peri-infarct cortical tissue in the acute and delayed phases of cerebral ischaemia.
    Patzer A; Zhao Y; Stöck I; Gohlke P; Herdegen T; Culman J
    Eur J Neurosci; 2008 Nov; 28(9):1786-94. PubMed ID: 18973594
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rosiglitazone, a PPARgamma ligand, modulates signal transduction pathways during the development of acute TNBS-induced colitis in rats.
    Sánchez-Hidalgo M; Martín AR; Villegas I; de la Lastra CA
    Eur J Pharmacol; 2007 May; 562(3):247-58. PubMed ID: 17343846
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.